Monographie - Diamorphine hydrochloride

Última actualização :
18/04/2024

Diamorphine hydrochloride

Estrutura química

Nomes comerciais nos diversos países

OS NOMES COMERCIAIS SÃO INDICATIVOS E OS EXCIPIENTES DA FORMULAÇÃO PODEM SER DIFERENTES CONFORME O PAÍS E FABRICANTE.

Diamorphine hydrochloride for injection	Gran-bretanha
Diaphin	Suicia

Bibliografía : Diamorphine hydrochloride

	Tipo	Publicação
339	Jornal	Kleinberg ML, Duafala ME, Nacov C, Flora KP, Hines J, Davis K, McDaniel A, Scott D. Stability of heroin hydrochloride in infusion devices and containers for intravenous administration. Am J Hosp Pharm 1990 ; 47: 377-381.
484	Jornal	Northcott M, Allsopp MA, Powell H, Sewell GJ. The stability of carboplatin, diamorphine, 5-fluorouracil and mitozantrone infusions in an ambulatory pump under storage and prolonged “in use” conditions. J Clin Pharm Ther 1991 ; 16: 123-129.
506	Jornal	Omar OA, Hoskin PJ, Johnston A, Hanks W, Turner P. Diamorphine stability in aqueous solution for subcutaneous infusion. J Pharm Pharmacol 1989 ; 41: 275-277.
512	Jornal	Barnes AR, Nash S. Stability of bupivacaine hydrochloride with diamorphine hydrochloride in an epidural infusion. Pharm World Sci 1995 ; 17: 87-92.
779	Jornal	Collins AJ, Abethell JA, Holmes SG, Rain R. Stability of diamorphine hydrochloride with haloperidol in prefilled syringes for continuous subcutaneous administration. J Pharm Pharmacol 1986 ; 38: 51P.
788	Jornal	Regnard CFB, Mannix K. Subcutaneous drug compatibility in palliative care. Lancet 1989 ; 2 (8670): 1044-1045.
1230	Jornal	Regnard C, Pashley S, Westrope F. Anti-emetic / diamorphine mixture compatibility in infusion pumps. Br J Pharm Pract 1986 ; 8: 218-220.
1232	Jornal	Beatson C, Taylor A. A physical compatibility study of furosemide & flucloxacillin injections. Br J Pharm Pract 1987 ; 9: 223-226, 236.
1288	Jornal	Allwood MC, Brown PW, Lee M. Stability of injections containing diamorphine and midazolam in plastic syringes. Int J Pharm Pract 1994 ; 3: 57-59.
1292	Jornal	Grassby PF, Roberts DE. Stability of epidural opiate solutions in 0.9 per cent sodium chloride infusion bags. Int J Pharm Pract 1995 ; 3: 174-177.
1385	Jornal	Kirk B, Hain WR. Diamorphine injection BP incompatibility. Pharm J 1985 ; 235: 171.
1388	Jornal	Page J, Hudson S. Diamorphine hydrochloride compatibility with saline. Pharm J 1982 ; 228: 238-239.
1886	Jornal	Allwood MC. The stability of diamorphine alone and in combinaison with antiemetics in plastic syringes. Palliative Med 1991 ; 5: 330-333.
2051	Jornal	Sanchez del Aguila MJ, Jones MF, Vohra A. Premixed solutions of diamorphine in ropivacaine for epidural anaesthesia: a study on long-term stability. Br J Anaesth 2003 ; 90: 179-182.
2307	Jornal	Kreeger L, Cowin P, Noble-Gresty J, Naysmith A. Epidural diamorphine and bupivacaine stability study. Palliative Med 1995 ; 9, 4: 315-318.
2308	Jornal	Hudson S.J, Jones M.F, Nolan S, Ellis H, Duncombe R, Alexander-Williams J.M. Stability of premixed syringes of diamorphine and hyperbaric bupivacaine. Int J Obstet Anesth 2005 ; 14, 4: 284-287.
2404	Jornal	Fielding H, Kyaterekera , Skellern GG, Tettey JN, McDade JR, ZMsuya Z, Watson DG, Urie J. The compatibility and stability of octreotide acetate in the presence of diamorphine hydrochloride in polypropylene syringes Palliative Med 2000 ; 14: 205-208.
3184	Laboratório	Hyaluronidase (Hyalase®) - Summary of Product characteristics. CP Pharmaceuticals 2005
3504	Laboratório	Parecoxib (Dynastat®) - Summary of Product Characteristics Pfizer 2012

Mentions Légales